Skip to content
value.today

Sylke, Inc.

🇺🇸 La Jolla, California, USAHealth CareFounded 2023
Total raised
$16 M
2 rounds on record
Latest round
$10 M
Mar 2025
First round on record
Aug 2024
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sylke, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2025$10 MNo. 2$10 to $50 million

Sylke, Inc.: Raise no. 2, Mar 2025

Investors in this round

63 investors had bought by the notice of Jul 17, 2025: 63 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,127,500 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Graham · Executive Officer
  • Jack Ferrier · Executive Officer
  • Mehrdad Mofid · Executive Officer, Director
  • Rebecca Badowski-Platz · Executive Officer
  • Scott Flowers · Executive Officer
  • Sheva Mokarrarm · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Payment of Indebtedness to executive officer.”

Signed by Alexander Graham, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 17, 2025. Read the notice at the SEC.

equitySEC
Aug 2024$6 MNo. 1$2 to $10 million

Sylke, Inc.: Raise no. 1, Aug 2024

Investors in this round

66 investors had bought by the notice of Sep 6, 2024: 66 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,096,201 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mehrdad Mofid · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Payment of indebtedness to executive officer and affiliates of executive officer.”

Signed by Mehrdad Mofid, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 6, 2024. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sylke, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2025).

    SEC Form D · Jul 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2025

That is all the official record says: Sylke, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sylke, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 66 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sylke, Inc.
NameRoleNamed in
Alexander GrahamExecutive officerJul 2025
Jack FerrierExecutive officerJul 2025
Mehrdad MofidExecutive officerJul 2025
Rebecca Badowski-PlatzExecutive officerJul 2025
Scott FlowersExecutive officerJul 2025
Sheva MokarrarmExecutive officerJul 2025
Mehrdad MofidDirectorJul 2025